SCN5A p.R219H-14C-ISO
CBRCULi016-A-1
General
Donor Information
General Donor Information |
|
Sex | male |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA114425090 |
Ethics
Also have a look at the ethics information for the parental line
CBRCULi016-A
.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
CBRCULi016-A.
|
|
Reprogramming method |
|
Vector type | None |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Medium |
mTeSR™ Plus
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
NANOG |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
||||
SOX2 |
Yes |
|
||||
TRA 1-60 |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
||||
TRA 1-81 |
Yes |
|
Differentiation Potency
In vitro directed differentiation
In vitro directed differentiation
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
XY - Normal
Karyotyping method:
KaryoStat+
|
Other Genotyping (Cell Line) |
Genetic Modification
Disease/phenotype related modifications |
|
Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.